Cargando…

Is pathological aging a successful resistance against amyloid-beta or preclinical Alzheimer’s disease?

Individuals with pathological aging, a form of cerebral amyloidosis in older people, have widespread extracellular amyloid-beta (Aβ) senile plaque deposits in the setting of limited neurofibrillary tau pathology. Unlike the characteristic finding of antemortem cognitive impairment in Alzheimer’s dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, Melissa E, Dickson, Dennis W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055017/ https://www.ncbi.nlm.nih.gov/pubmed/25031637 http://dx.doi.org/10.1186/alzrt254

Ejemplares similares

Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
por: Castello, Michael A, et al.
Publicado: (2014)

Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity
por: Bonifacio, Ezio, et al.
Publicado: (2016)

Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus
por: Maassen, J. A., et al.
Publicado: (2007)

Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
por: Huber, Colin M., et al.
Publicado: (2017)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Integrating pathology and radiology disciplines: an emerging opportunity?
por: Sorace, James, et al.
Publicado: (2012)

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
por: Mullins, Roger J., et al.
Publicado: (2017)

Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology
por: Hefner, Marleigh, et al.
Publicado: (2021)

Is the risk of Alzheimer’s disease and dementia declining?
por: Langa, Kenneth M
Publicado: (2015)

Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease
por: Zagorski, Karen, et al.
Publicado: (2023)

Beta-amyloid and Cortical Thickness Reveal Racial Disparities in Preclinical Alzheimer's Disease
por: McDonough, Ian M.
Publicado: (2017)

Quality of Life as an outcome in Alzheimer's disease and other dementias- obstacles and goals
por: Riepe, Matthias W, et al.
Publicado: (2009)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?
por: Devi, Gayatri, et al.
Publicado: (2018)

Novel biotechnological approaches for monitoring and immunization against resistant to antibiotics Escherichia coli and other pathogenic bacteria
por: Belizário, José E., et al.
Publicado: (2020)

White matter pathology – an endophenotype for bipolar disorder?
por: Borgwardt, Stefan, et al.
Publicado: (2012)

Can animal data translate to innovations necessary for a new era of patient-centred and individualised healthcare? Bias in preclinical animal research
por: Green, Susan Bridgwood
Publicado: (2015)

Pro: Alzheimer's disease and circadian dysfunction: chicken or egg?
por: Bedrosian, Tracy A, et al.
Publicado: (2012)

Con: Alzheimer's disease and circadian dysfunction: chicken or egg?
por: Moghekar, Abhay, et al.
Publicado: (2012)

High adiposity: risk factor for dementia and Alzheimer’s disease?
por: Gustafson, Deborah R, et al.
Publicado: (2013)

Inexplicable COVID-19! Would pathological autopsy be the panacea?
por: Parekh, Utsav, et al.
Publicado: (2021)

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against
por: Krishna, Sanjeev
Publicado: (2019)

An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology
por: Rybaczyk, Leszek A, et al.
Publicado: (2005)

Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
por: Lathe, Richard, et al.
Publicado: (2014)

Setting priorities in health care organizations: criteria, processes, and parameters of success
por: Gibson, Jennifer L, et al.
Publicado: (2004)

Drug discovery in ophthalmology: past success, present challenges, and future opportunities
por: Gower, Nicholas J. D., et al.
Publicado: (2016)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Effects of DDT on Amyloid Precursor Protein Levels and Amyloid Beta Pathology: Mechanistic Links to Alzheimer’s Disease Risk
por: Eid, Aseel, et al.
Publicado: (2022)

Research involving subjects with Alzheimer’s disease in Italy: the possible role of family members
por: Porteri, Corinna, et al.
Publicado: (2015)

Successful recruitment to trials: a phased approach to opening gates and building bridges
por: Patterson, Sue, et al.
Publicado: (2011)

PARIHS revisited: from heuristic to integrated framework for the successful implementation of knowledge into practice
por: Harvey, Gill, et al.
Publicado: (2016)

Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?
por: Rafii, Michael S
Publicado: (2014)

Con: are we ready to translate Alzheimer’s disease-modifying therapies to people with down syndrome?
por: Head, Elizabeth, et al.
Publicado: (2014)

A critical review of population health literacy assessment
por: Guzys, Diana, et al.
Publicado: (2015)

What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?
por: Watson, Robert A, et al.
Publicado: (2011)

Ukrainian health care system and its chances for successful transition from Soviet legacies
por: Romaniuk, Piotr, et al.
Publicado: (2018)

An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists
por: Kolb-Mäurer, Annette, et al.
Publicado: (2019)

Advance directives as a tool to respect patients’ values and preferences: discussion on the case of Alzheimer’s disease
por: Porteri, Corinna
Publicado: (2018)

Evaluating the successful implementation of evidence into practice using the PARiHS framework: theoretical and practical challenges
por: Kitson, Alison L, et al.
Publicado: (2008)

How to successfully select and implement electronic health records (EHR) in small ambulatory practice settings
por: Lorenzi, Nancy M, et al.
Publicado: (2009)

Knowledge transfer in the field of parental mental illness: objectives, effective strategies, indicators of success, and sustainability
por: Lauritzen, Camilla, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p509n7dnhc0vrh6rnlofr4edet